SCREENING AFTER STROKE - ATRIAL FIBRILLATION
Recruiting · NCT06675383 · Observational (researchers observe without assigning treatment) · Lead sponsor: Vestre Viken Hospital Trust
View the official record on ClinicalTrials.gov →What this trial is about
As much as 20-30% of all strokes are attributed to atrial fibrillation (AF), making the detection of AF highly important, as AF-related strokes are largely preventable with optimal treatment. Therefore, most guidelines recommend screening patients for AF after a stroke, although the optimal timing and choice of monitoring device for screening remain undefined. Our aim is to investigate whether AF screening as early as possible after stroke symptom onset provides a higher detection rate compared to screening after discharge. Additionally, we aim to determine if a 3-lead ECG device provides a higher detection rate compared to a 1-lead patch recorder.
Who can take part
Inclusion criteria
- 18 years or older
- Ischemic stroke
- Without known AF or those with previously diagnosed paroxysmal AF exhibiting sinus rhythm upon admission
Exclusion criteria
- AF at hosptial admission
- Unable or unwilling to provide informed consent
- A life expectancy of less than one year
Where it is running
1 location listed.
- Vestre Viken Hospital trust, Baerum Hospital - Sogneprest Munthe-kaas Vei 100, Gjettum, Norway